Provided by Tiger Fintech (Singapore) Pte. Ltd.

COSMOS HEALTH INC

0.3576
+0.040012.59%
Volume:476.76K
Turnover:165.19K
Market Cap:9.73M
PE:-0.31
High:0.3750
Open:0.3333
Low:0.3105
Close:0.3176
Loading ...

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

ACCESS Newswire
·
07 Feb

Cosmos Health Files Patent Application for Multiple Sclerosis Treatment

MT Newswires Live
·
06 Feb

Cosmos Health files patent application for multiple sclerosis treatment

TIPRANKS
·
06 Feb

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

ACCESS Newswire
·
06 Feb

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

ACCESS Newswire
·
29 Jan

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

ACCESS Newswire
·
28 Jan

BRIEF-Cosmos Health Signs Expanded Exclusive Distribution Agreement With Virax Biolabs For Avian Influenza Virus PCR Kits

Reuters
·
24 Jan

Cosmos Health: Expanded Exclusive Distribution Agreement With Virax Biolabs for Avian Influenza Virus Pcr Kits in Saudi Arabia, UAE, Qatar, Kuwait

THOMSON REUTERS
·
24 Jan

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

ACCESS Newswire
·
24 Jan

Cosmos Health secures rights, exclusive licensing for two anticancer drugs

TIPRANKS
·
22 Jan

Cosmos Health Inc - on Dec 31, Enters Patent & Technology License Agreement With Docpharma Single Sa

THOMSON REUTERS
·
22 Jan

Cosmos Health - Docpharma Single Sa. Granted the Co a Exclusive Worldwide License for Cancer Treatment Patents

THOMSON REUTERS
·
22 Jan

Cosmos Health Inc - Has Buy-Out Right for EUR 7.5 Million

THOMSON REUTERS
·
22 Jan

Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

ACCESS Newswire
·
22 Jan

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

ACCESS Newswire
·
22 Jan

Cosmos Health to Distribute Virax Avian Influenza PCR Kits in Europe, GCC Countries

MT Newswires Live
·
13 Jan

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

ACCESSWIRE
·
13 Jan

BRIEF-Cosmos Health Files For Offering Of Up To 10.7 Mln Shares Of Common Stock

Reuters
·
06 Jan

Cosmos Health Inc Files for Offering of up to 10.7 Mln Shares of Common Stock -SEC Filing

THOMSON REUTERS
·
06 Jan

Cosmos Health appoints Dimitrios Trafalis as head of oncology

TIPRANKS
·
27 Dec 2024